• Publications
  • Influence
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
BACKGROUND Whether long-term suppression of replication of hepatitis B virus (HBV) has any beneficial effect on regression of advanced liver fibrosis associated with chronic HBV infection remainsExpand
  • 1,069
  • 42
  • PDF
Hepatitis E Virus Epidemiology in Industrialized Countries
To determine the prevalence of Hepatitis E virus (HEV) in industrialized nations, we analyzed the excretion of HEV strains by the populations of Spain, France, Greece, Sweden, and the United States.Expand
  • 283
  • 25
  • PDF
HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain.
BACKGROUND/AIMS Hepatitis E virus (HEV) is an enterically transmitted pathogen that appears sporadically in non-endemic countries. We studied HEV as a causal agent of acute hepatitis cases in theExpand
  • 244
  • 24
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed,Expand
  • 387
  • 21
  • PDF
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Background and Aim: Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country‐specific data on riskExpand
  • 388
  • 20
[Hepatitis B virus genotypes].
  • M. Butí
  • Medicine
  • Gastroenterologia y hepatologia
  • 2003
  • 166
  • 20
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.
BACKGROUND/AIMS Previous studies using standard interferon and ribavirin combination therapy suggested that patients infected with HCV-1 and a low pretreatment HCV-RNA level can be treated for 24Expand
  • 498
  • 19
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer.
The natural history of cancers associated with virus exposure is intriguing, since only a minority of human tissues infected with these viruses inevitably progress to cancer. However, the molecularExpand
  • 220
  • 18
  • PDF
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
BACKGROUND Treatment options are limited for patients infected by hepatitis C virus (HCV) with advanced liver disease. We assessed the safety and efficacy of ledipasvir, sofosbuvir, and ribavirin inExpand
  • 334
  • 16
  • PDF
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies and migration. This Clinical PracticeExpand
  • 1,445
  • 15
  • PDF